The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients
Abstract
Several lines of evidence suggest that D-serine, an endogenous agonist of the glycine site on the NMDA receptors, might play a role in the pathophysiology of schizophrenia. The purpose of this study was to determine whether levels of D- and L-serine or D-serine ratio (D-serine/total serine) in cerebrospinal fluid (CSF) were altered in first episode and drug-naive schizophrenic patients. The CSF levels of D- and L-serine in 25 male first episode and drug-naive schizophrenic patients and 17 age-matched male healthy subjects were measured using a column-switching high performance liquid chromatography system. The percentage of D-serine in the total serine of patients was significantly (z = -2.01, p = 0.044) lower than that of controls. This study suggests that synthetic or metabolic pathways of D-serine may be abnormal in the brain of drug-naive schizophrenic patients, supporting the NMDA receptor dysfunction hypothesis of schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Post-mortem studies of the brain of patients with schizophrenia have revealed lower levels of expression of the obligate NMDAR subunit GRIN1 (glutamate receptor ionotropic, NMDA 1), increases in the expression of the endogenous NMDAR antagonist kynurenate, and a reduction in levels of the NMDAR co-agonist D-serine and the enzyme that catalyses its production, D-serine racemase 10,[16][17][18] .”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [17]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Diagnostic and Statistical Manual of Mental Disorders
&NA; (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00022 · Cited by 12,603
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia
GOFF, D. C., & Coyle, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1367 · Cited by 926
Decreased Serum Levels of D-Serine in Patients With Schizophrenia
Hashimoto, K., Fukushima, T., Shimizu, E., Komatsu, N., Watanabe, H., 篠田, 直., Nakazato, M., Kumakiri, C., Okada, S.-I., Hasegawa, H., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.572 · Cited by 489
Self-citationSchizophrenia and Glutamatergic Transmission
Tamminga, C. A. (1998) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v12.i1-2.20 · Cited by 382
Free d-aspartate and d-serine in the mammalian brain and periphery
Hashimoto, A., & Oka, T. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00019-1 · Cited by 332
Novel Neurotransmitters and Their Neuropsychiatric Relevance
Snyder, S. H., & Ferris, C. D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1738 · Cited by 263
Dysfunction of Glia-Neuron Communication in Pathophysiology of Schizophrenia
Hashimoto, K., Shimizu, E., & Iyo, M. (2005) · Current Psychiatry Reviews · doi:10.2174/1573400054065569 · Cited by 75
Self-citation
Cited by
Sorted by citations
Items 101–200 of 272
Modulation of NMDA receptor function by inhibition of d-amino acid oxidase in rodent brain
Strick, C. A., Li, C., Scott, L., Harvey, B., Hajós, M., Steyn, S. J., Piotrowski, M. A., James, L. C., Downs, J. T., Rago, B., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.029 · Cited by 42
Luca, C. D., Felletti, S., Franchina, F. A., Bozza, D., Compagnin, G., Nosengo, C., Pasti, L., Cavazzini, A., & Catani, M. (2023) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2023.115794 · Cited by 40
Hashimoto, K. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1063-7 · Cited by 39
Self-citationMcGarry, A. J., Gaughan, J., Hackmyer, C., Lovett, J., Khadeer, M., Shaikh, H. A., Pradhan, B., Ferraro, T. N., Wainer, I. W., & Moaddel, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-77526-9 · Cited by 40
Fujita, Y., Ishima, T., & Hashimoto, K. (2016) · Scientific Reports · doi:10.1038/srep37261 · Cited by 39
Self-citationHabl, G., Zink, M., Petroianu, G. A., Bauer, M., Schneider-Axmann, T., von Wilmsdorff, M., Falkai, P., Henn, F. A., & Schmitt, A. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0312-z · Cited by 39
Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain
Rosa, A. D., Fontana, A., Nuzzo, T., Garofalo, M., Maio, A. D., Punzo, D., Copetti, M., Bertolino, A., Errico, F., Rampino, A., et al. (2022) · Schizophrenia · doi:10.1038/s41537-022-00231-1 · Cited by 38
d-Serine: The right or wrong isoform?
Fuchs, S. A., Berger, R., & de Koning, T. J. (2011) · Brain Research · doi:10.1016/j.brainres.2011.05.039 · Cited by 36
D-Aspartate: An Atypical Amino Acid with Neuromodulatory Activity in Mammals
Errico, F., Napolitano, F., Nisticò, R., Centonze, D., & Usiello, A. (2009) · Reviews in the Neurosciences · doi:10.1515/revneuro.2009.20.5-6.429 · Cited by 37
Fradley, R. L., Goetghebeur, P., Miller, D., Burley, R., Almond, S., Gruart, A., García, J. M. D., Zhu, B., Howley, E., Neill, J. C., et al. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03956-2 · Cited by 36
Egerton, A., Fusar-Poli, P., & M. Stone, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799316244 · Cited by 36
Pritchett, D., Hasan, S., Tam, S. K. E., Engle, S. J., Brandon, N. J., Sharp, T., Foster, F., Harrison, P. J., Bannerman, D. M., & Peirson, S. N. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12880 · Cited by 34
Roussos, P., Giakoumaki, S. G., Adamaki, E., Georgakopoulos, A., Nikos, R. K., & Bitsios, P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.49 · Cited by 35
Brouwer, A., Luykx, J. J., van Boxmeer, L., Bakker, S. C., & Kahn, R. S. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.06.007 · Cited by 35
Sacchi, S., Cappelletti, P., & Murtas, G. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00055 · Cited by 37
Rømer, T. B., Jeppesen, R., Christensen, R. H. B., & Benros, M. E. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02059-2 · Cited by 33
Hagiwara, H., Iyo, M., & Hashimoto, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062438 · Cited by 33
Self-citationSchmitt, A., Rujescu, D., Gawlik, M., Hasan, A., Hashimoto, K., Iceta, S., Jarema, M., Kambeitz, J. P., Kasper, S. F., Keeser, D., et al. (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1183043 · Cited by 39
Self-citationKeller, S., Punzo, D., Cuomo, M., Affinito, O., Coretti, L., Sacchi, S., Florio, E., Lembo, F., Carella, M., Copetti, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28332-x · Cited by 35
Glycine Transporter Inhibitors as Therapeutic Agents for Schizophrenia
Hashimoto, K. (2006) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488906775245336 · Cited by 33
Self-citationCappelletti, P., Campomenosi, P., Pollegioni, L., & Sacchi, S. (2013) · FEBS Journal · doi:10.1111/febs.12616 · Cited by 32
Ohnuma, T., & Arai, H. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.027 · Cited by 31
Direct chromatographic methods for enantioresolution of amino acids: recent developments
Carenzi, G. E. A., Sacchi, S., Abbondi, M., & Pollegioni, L. (2020) · Amino Acids · doi:10.1007/s00726-020-02873-w · Cited by 31
Psychosis and relapse in bipolar disorder are related to GRM3, DAOA, and GRIN2B genotype
Ramesar, R., Dalvie, S., Horn, N. R., Nossek, C., van der Merwe, L., & Stein, D. J. (2010) · African Journal of Psychiatry · doi:10.4314/ajpsy.v13i4.61880 · Cited by 32
Zhang, H., Qi, L., Qiao, J., & Mao, L. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.02.039 · Cited by 31
d-Amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia
Corvin, A. P., Donohoe, G. J., McGhee, K. A., Murphy, K. J., Kenny, N., Schwaiger, S., Nangle, J. M., Morris, D. W., & Gill, M. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.09.002 · Cited by 31
Katane, M., Kawata, T., Nakayama, K., Saitoh, Y., Kaneko, Y., Matsuda, S., Saitoh, Y., Miyamoto, T., Sekine, M., & Homma, H. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00690 · Cited by 30
Cao, T., Li, N., & Cai, H. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.03.009 · Cited by 30
Clinical and biochemical study of D-serine metabolism among schizophrenia patients
El-Tallawy, H. N., Saleem, T. H., El-Ebidi, A. M., Hassan, M. H., Gabra, R. H., Farghaly, W. M. A., El‐Maali, N. A., & Sherkawy, H. S. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s126979 · Cited by 29
d-Amino Acids and pLG72 in Alzheimer’s Disease and Schizophrenia
Cheng, Y., Lin, C., & Lane, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010917 · Cited by 30
Liu, R., Dang, W., Du, Y., Zhou, Q., Liu, Z., & Jiao, K. (2015) · Gene · doi:10.1016/j.gene.2015.05.011 · Cited by 27
Cerebrospinal fluid: identification of diagnostic markers for schizophrenia
Schwarz, E., & Bahn, S. (2008) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.2.209 · Cited by 27
Hons, J., Žirko, R., Vašatová, M., Doubek, P., Klímová, B., Masopust, J., Vališ, M., & Kuča, K. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.514579 · Cited by 28
Seetharam, J. C., Maiti, R., Mishra, A., & Mishra, B. R. (2021) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2021.102947 · Cited by 29
D-Amino Acids as a Biomarker in Schizophrenia
Taniguchi, K., Sawamura, H., Ikeda, Y., Tsuji, A., Kitagishi, Y., & Matsuda, S. (2022) · Diseases · doi:10.3390/diseases10010009 · Cited by 28
Nomura, J., Jaaro-Peled, H., Lewis, E. M., Nunez‐Abades, P., Huppé‐Gourgues, F., Cash-Padgett, T. V., Emiliani, F. E., Kondo, M., Furuya, A., Landek‐Salgado, M. A., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.61 · Cited by 30
Saitoh, Y., Katane, M., Kawata, T., Maeda, K., Sekine, M., Furuchi, T., Kobuna, H., Sakamoto, T., Inoue, T., Arai, H., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06513-11 · Cited by 26
Advances in the Treatment of Cognitive Impairment in Schizophrenia: Targeting NMDA Receptor Pathways
Zhang, T., Liu, C., Zhong, N., Wang, Y., Huang, Y., & Zhang, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910668 · Cited by 26
Kalíková, K., Šlechtová, T., & Tesařová, E. (2016) · Separations · doi:10.3390/separations3040030 · Cited by 25
Transport systems of serine at the brain barriers and in brain parenchymal cells
Kasai, Y., Tachikawa, M., Hirose, S., Akanuma, S., & Hosoya, K. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07313.x · Cited by 25
Mutant Mice and Rats Lacking D ‐Amino Acid Oxidase
Konno, R., Hamase, K., Maruyama, R., & Zaitsu, K. (2010) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900303 · Cited by 25
Seabra, G., de Almeida, V., Reis‐de‐Oliveira, G., Crunfli, F., Antunes, A. S. L. M., & Martins‐de‐Souza, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-69543-5 · Cited by 24
Katane, M., Yamada, S., Kawaguchi, G., Chinen, M., Matsumura, M., Ando, T., Doi, I., Nakayama, K., Kaneko, Y., Matsuda, S., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00871 · Cited by 24
Sikka, P., Walker, R. M., Cockayne, R., Wood, M. J. A., Harrison, P. J., & Burnet, P. W. J. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22332 · Cited by 23
Seki, T., Sato, M., Konno, A., Hirai, H., Kurauchi, Y., Hisatsune, A., & Katsuki, H. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.10.002 · Cited by 23
Solid-state vibrational circular dichroism studies of L- and D-serine
Kawamura, I., & Sato, H. (2019) · Analytical Biochemistry · doi:10.1016/j.ab.2019.05.016 · Cited by 23
Ohnuma, T., Shibata, N., Maeshima, H., Baba, H., Hatano, T., Hanzawa, R., & Arai, H. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.02.004 · Cited by 23
Papagni, S. A., Mechelli, A., Prata, D. P., Kambeitz, J. P., Fu, C. H. Y., Picchioni, M., Walshe, M., Toulopoulou, T., Bramon, E., Murray, R. M., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.03.037 · Cited by 22
Misiak, B., Frydecka, D., Piotrowski, P., & Kiejna, A. (2013) · Epigenomics · doi:10.2217/epi.13.22 · Cited by 22
Yoshikawa, K., Furuno, M., Tanaka, N., & Fukusaki, E. (2020) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2020.05.007 · Cited by 22
D-amino acids in normal ageing and pathogenesis of neurodegenerative diseases
Chervyakov, A. V., Gulyaeva, N. V., & Zakharova, M. N. (2011) · Neurochemical Journal · doi:10.1134/s1819712411020036 · Cited by 22
Puhl, M. D., Desai, R. I., Takagi, S., Presti, K. T., Doyle, M. R., Donahue, R. J., Landino, S. M., Bergman, J., Carlezon, W. A., & Coyle, J. T. (2017) · Addiction Biology · doi:10.1111/adb.12577 · Cited by 22
Lella, C., Nestor, L., Bundel, D. D., Heyden, Y. V., & Eeckhaut, A. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212410 · Cited by 20
Ozeki, Y., Sekine, M., Fujii, K., Watanabe, T., Okayasu, H., Takano, Y., Shinozaki, T., Aoki, A., Akiyama, K., Homma, H., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.01.010 · Cited by 21
Drews, E., Otte, D.-M., & Zimmer, A. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.009 · Cited by 24
D-Serine in Neuropsychiatric Disorders: New Advances
Durrant, A. R., & Heresco‐Levy, U. (2014) · Advances in Psychiatry · doi:10.1155/2014/859735 · Cited by 21
Handbook of neurochemistry and molecular neurobiology, schizophrenia
Lajtha, Á., Javitt, D. C., & Kantrowitz, J. T. (2009) · Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) · doi:10.1007/978-0-387-30410-6 · Cited by 21
Onozato, M., Tanaka, Y., Arita, M., Sakamoto, T., Ichiba, H., Sadamoto, K., Kondo, M., & Fukushima, T. (2018) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2018.e00099 · Cited by 20
Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease
Imarisio, A., Yahyavi, I., Avenali, M., Maio, A. D., Buongarzone, G., Galandra, C., Picascia, M., Filosa, A., Gasparri, C., Monti, M. C., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106413 · Cited by 20
Protein interacting with C kinase and neurological disorders
Focant, M. C., & Hermans, E. (2013) · Synapse · doi:10.1002/syn.21657 · Cited by 20
Lu, X., Jie, L., Liu, C.-W., & Zhao, S. (2007) · Chinese Journal of Analytical Chemistry · doi:10.1016/s1872-2040(07)60076-0 · Cited by 20
Sugimoto, H., Kakehi, M., & Jinno, F. (2015) · Analytical Biochemistry · doi:10.1016/j.ab.2015.07.004 · Cited by 19
Metformin reverses the schizophrenia-like behaviors induced by MK-801 in rats
Wang, X., Luo, C., Mao, X., Li, X., Yin, J., Zhang, W., Zhou, H., & Liu, Z. (2019) · Brain Research · doi:10.1016/j.brainres.2019.05.023 · Cited by 19
Serine enantiomers as diagnostic biomarkers for schizophrenia and bipolar disorder
Hashimoto, K. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-015-0602-4 · Cited by 19
Self-citationVariations of blood D-serine and D-aspartate homeostasis track psychosis stages
Rampino, A., Garofalo, M., Nuzzo, T., Favia, M., Saltarelli, S., Masellis, R., Asselti, M. G., Pennacchio, T. C., Bruzzese, D., Errico, F., et al. (2024) · Schizophrenia · doi:10.1038/s41537-024-00537-2 · Cited by 21
Bifone, A., & Gozzi, A. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.724057 · Cited by 18
Imarisio, A., Yahyavi, I., Gasparri, C., Hassan, A., Avenali, M., Maio, A. D., Buongarzone, G., Galandra, C., Picascia, M., Filosa, A., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02991-z · Cited by 17
Decreased free D-aspartate levels in the blood serum of patients with schizophrenia
Garofalo, M., Simone, G. D., Motta, Z., Nuzzo, T., Grandis, E. D., Bruno, C., Boeri, S., Riccio, M. P., Pastore, L., Bravaccio, C., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1408175 · Cited by 16
Nagai, T., Yu, J., Kitahara, Y., Nabeshima, T., & Yamada, K. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12142fp · Cited by 17
Maekawa, M., Ohnishi, T., Hashimoto, K., Watanabe, A., Iwayama, Y., Ohba, H., Hattori, E., Yamada, K., & Yoshikawa, T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07039.x · Cited by 17
Self-citationSimultaneous Analysis of d- and l-Serine in Cerebrospinal Fluid by Use of HPLC
Sethuraman, R., Krishnamoorthy, M. G., Lee, T., Liu, E. H. C., Chiang, S., Nishimura, W., Sakai, M., Minami, T., & Tachibana, S. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.086702 · Cited by 17
Matsumoto, Y., Niwa, M., Mouri, A., Noda, Y., Fukushima, T., Ozaki, N., & Nabeshima, T. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4704-8 · Cited by 15
Sensory-targeted cognitive training for schizophrenia
Dondé, C., Mondino, M., Brunelin, J., & Haesebaert, F. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1581609 · Cited by 16
Katane, M., Saitoh, Y., Uchiyama, K., Nakayama, K., Saitoh, Y., Miyamoto, T., Sekine, M., Uda, K., & Homma, H. (2016) · Genes to Cells · doi:10.1111/gtc.12398 · Cited by 14
Jagannath, V., Brotzakis, Z. F., Parrinello, M., Walitza, S., & Grünblatt, E. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00342 · Cited by 13
Different serine and glycine metabolism in patients with schizophrenia receiving clozapine
Hons, J., Vašatová, M., Čermáková, E., Doubek, P., & Libiger, J. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.03.015 · Cited by 14
Abnormalities of the glutamine–glutamate–GABA cycle in the schizophrenia brain
Hashimoto, K. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.04.008 · Cited by 14
Self-citationShindo, T., Shikanai, H., Watarai, A., Hiraide, S., Iizuka, K., & Izumi, T. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174930 · Cited by 13
Yao, P.-H. E., Kumar, S., Liu, Y., Fang, C.-P., Liu, C., & Sun, C. (2017) · ACS Combinatorial Science · doi:10.1021/acscombsci.7b00004 · Cited by 13
Katane, M., & Homma, H. (2024) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b23-00485 · Cited by 12
The Importance of Cerebrospinal Fluid Investigation in First-episode Psychosis
Pavăl, D., Gherghel, N., Căpățînă, O., Stan, A. D., Micluția, I., & Giné-Servén, E. (2023) · The Yale Journal of Biology and Medicine · doi:10.59249/oamt2710 · Cited by 12
The Antiviral Drug Acyclovir Is a Slow-Binding Inhibitor of d -Amino Acid Oxidase
Katane, M., Matsuda, S., Saitoh, Y., Sekine, M., Furuchi, T., Koyama, N., Nakagome, I., Tomoda, H., Hirono, S., & Homma, H. (2013) · Biochemistry · doi:10.1021/bi400478a · Cited by 12
da Silva, L. D. B., Leipnitz, G., Seminotti, B., Fernandes, C. G., Beskow, A. P., Amaral, A. U., & Wajner, M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.12.036 · Cited by 12
Panizzutti, R., Scoriels, L., & Avellar, M. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612819666140110121139 · Cited by 12
Glutamatergic Approaches to the Conceptualization and Treatment of Schizophrenia
Kantrowitz, J. T., & Javitt, D. C. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_3 · Cited by 12
Zanatta, Â., Schuck, P. F., Viegas, C. M., Knebel, L. A., Busanello, E. N. B., Moura, A. P., & Wajner, M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.08.080 · Cited by 11
Kozaki, A. (2012) · BioScience Trends · doi:10.5582/bst.2012.v6.5.241 · Cited by 11
The effect of G72 genotype on neural correlates of memory encoding and retrieval
Jansen, A., Krach, S., Krug, A., Markov, V., Thimm, M., Paulus, F. M., Zerres, K., Stöcker, T., Shah, N. J., Nöthen, M. M., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.12.018 · Cited by 10
Hassan, A., di Vito, R., Nuzzo, T., Vidali, M., Carlini, M. J., Yadav, S., Yang, H., D’Amico, A., Kolici, X., Valsecchi, V., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106849 · Cited by 16
Structural and enzymatic properties of mammalian d-glutamate cyclase
Katane, M., Ariyoshi, M., Tateishi, S., Koiwai, S., Takaku, K., Nagai, K., Nakayama, K., Saitoh, Y., Miyamoto, T., Sekine, M., et al. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.07.005 · Cited by 9
Cross species review of the physiological role of d-serine in translationally relevant behaviors
Arizanovska, D., Emodogo, J., Lally, A. P., Palavicino‐Maggio, C. B., Liebl, D. J., & Folorunso, O. O. (2023) · Amino Acids · doi:10.1007/s00726-023-03338-6 · Cited by 9
Camporesi, S., Xin, L., Golay, P., Eap, C. B., Cleusix, M., Cuénod, M., Fournier, M., Hashimoto, K., Jenni, R., Ramain, J., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02631-4 · Cited by 10
Self-citationLeipnitz, G., da Silva, L. D. B., Fernandes, C. G., Seminotti, B., Amaral, A. U., Dutra‐Filho, C. S., & Wajner, M. (2010) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.03.002 · Cited by 9
Jimenez, N. T., Lines, J., Kueppers, R. B., Kofuji, P., Wei, H. G., Rankila, A., Coyle, J. T., Miller, R. F., & McLoon, L. K. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.2.16 · Cited by 9
Separation and detection of D-/L-serine by conventional HPLC
Shikanai, H., Ikimura, K., Miura, M., Shindo, T., Watarai, A., & Izumi, T. (2022) · MethodsX · doi:10.1016/j.mex.2022.101752 · Cited by 9
Impact of D-Amino Acids in Schizophrenia
Dursun, S. M., Dursun, L. H., & Baker, G. B. (2025) · Biomolecules · doi:10.3390/biom15091270 · Cited by 10
Uzun, E., Tomruk, N. B., Şen, C. Ç., & Yıldızhan, E. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.05.004 · Cited by 8
Structural basis for potent inhibition of d-amino acid oxidase by thiophene carboxylic acids
Kato, Y., Hin, N., Maita, N., Thomas, A. G., Kurosawa, S., Rojas, C. J., Yorita, K., Slusher, B. S., Fukui, K., & Tsukamoto, T. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.040 · Cited by 8
Yao, L., Wang, Z., Deng, D., Yan, R., Ju, J., & Zhou, Q. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2306-1 · Cited by 8
Svane, K. C., Asis, E.-K., Omelchenko, A., Kunnath, A. J., Brzustowicz, L. M., Silverstein, S. M., & Firestein, B. L. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.03.011 · Cited by 8
Metadata
- Authors
- Hashimoto, K., Engberg, G., Shimizu, E., Nordin, C., Lindström, L. H., & Iyo, M.
- Affiliations
- Chiba University (JP)
- Karolinska Institutet (SE)
- Linköping University Hospital (SE)
- Uppsala University (SE)
- Corresponding author
- Hashimoto, Kenji
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 29
- Issue
- 5
- Pages
- 767-769
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2078450450
- Cited by
- 267
- References
- 13
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 11 · 2023: 10 · 2022: 6 · 2021: 7 · 2020: 12 · 2019: 18 · 2018: 15 · 2017: 12 · 2016: 16 · 2015: 13 · 2014: 12 · 2013: 14 · 2012: 14
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- D-serine, L-serine, cerebrospinal fluid, schizophrenia, first-episode schizophrenia, drug-naive patients, NMDA receptor, serine metabolism
- MeSH terms
- Adolescent, Adult, Chromatography, High Pressure Liquid, Humans, Male, Schizophrenia, Serine, Stereoisomerism, Receptors, N-Methyl-D-Aspartate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
